ICD-10 Code F11.20: Opioid Dependence, Uncomplicated

Key Takeaways

F11.20 is a billable ICD-10-CM code for Opioid dependence, uncomplicated, classified under Chapter 5: Mental, Behavioral and Neurodevelopmental disorders.

Use F11.20 for moderate or severe OUD without active withdrawal, intoxication, or other documented complications.

Confusing F11.20 (dependence) with F11.10 (abuse, uncomplicated) is a common audit trigger; clinical documentation must support the dependence diagnosis.

Pabau’s claims management software helps OUD treatment practices track F11.20 billing accuracy and reduce claim denials.

Opioid use disorder billing gets denied more often than almost any other behavioral health claim. A single coding error between F11.10 and F11.20 can trigger an audit, delay payment, or result in a recoupment demand from Medicare or Medicaid. For practices treating patients with opioid dependence, getting ICD 10 Code F11.20 right the first time is not just a billing concern; it is a documentation and compliance responsibility.

This reference guide covers the official clinical definition of ICD 10 Code F11.20, its billable status under the 2026 ICD-10-CM code set, documentation requirements, related subcategory codes, DSM-5 alignment, and billing guidance for healthcare providers treating opioid use disorder. Clinics using mental health EMR software will find the coding workflow context particularly useful.

ICD 10 Code F11.20: Opioid Dependence, Uncomplicated

ICD 10 Code F11.20 is a billable and specific diagnosis code in the 2026 ICD-10-CM code set, maintained jointly by the Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS). Its official descriptor is Opioid dependence, uncomplicated. The code is classified under Chapter 5: Mental, Behavioral and Neurodevelopmental disorders (F01-F99), within the subcategory F10-F19 (Mental and behavioral disorders due to psychoactive substance use).

“Uncomplicated” in this context means the patient meets criteria for opioid dependence but does not currently present with withdrawal, intoxication, or other coded complications at the time of the encounter. The absence of a complication suffix does not imply the patient is stable or in low-risk status; it means no additional complication modifier applies to this specific encounter.

ICD 10 Code F11.20 Inclusion Terms and Code Notes

The ICD-10-CM Tabular List includes Applicable To terms under F11.20 that confirm the code applies to opioid dependence broadly, not only street opioid use. Clinicians treating patients dependent on prescription opioids for nonmedical purposes may also correctly apply this code, provided the dependence criteria are met. It is important to distinguish between official Tabular List inclusion terms and clinical scenarios that map to F11.20 by inference.

• Opioid dependence (uncomplicated, no active withdrawal or intoxication)
• Prescription opioid dependence (nonmedical use, when dependence criteria are met)

A note on two commonly associated terms: Methadone dependence, uncomplicated is a clinical scenario that maps to F11.20 when the patient is dependent on methadone as a substance of misuse (not when receiving it therapeutically for OUD). However, “Methadone dependence, uncomplicated” is not explicitly listed as an Applicable To term in the FY2026 Tabular List – it is a clinical inference based on the code’s scope. Similarly, “Opioid use, harmful” is a concept from the WHO’s ICD-10 international classification that does not map directly to ICD-10-CM’s abuse/dependence framework. In the WHO system, “harmful use” aligns more closely with the ICD-10-CM abuse category (F11.1x) than with dependence (F11.2x). Including it as a synonym for F11.20 risks confusing coders who work across both classification systems. The distinction between official Tabular List inclusion terms and clinical inferences matters for audit documentation.

• Clinical scenarios that map to F11.20 (not Tabular List inclusion terms): Methadone dependence (nontherapeutic use), heroin dependence (uncomplicated), fentanyl dependence (uncomplicated)

One frequent source of coding errors involves methadone. ICD 10 Code F11.20 applies when a patient is dependent on methadone itself as a substance. It does not apply to patients receiving methadone as medication-assisted treatment (MOUD) for opioid use disorder, where Z79.891 (long-term use of opioid analgesic) is the appropriate supplemental code.

When to Use ICD 10 Code F11.20

Apply ICD 10 Code F11.20 when the clinical record supports an active opioid dependence diagnosis and the encounter does not involve documented withdrawal, intoxication, or perceptual disturbances. The following criteria help determine appropriate use, as established by WHO’s ICD-10 classification framework and the ICD-10-CM Official Guidelines for Coding and Reporting (FY2026).

• Patient has a documented opioid dependence diagnosis (not merely opioid abuse or use)
• Current encounter does not involve active opioid withdrawal (use F11.23 if withdrawal is present)
• Patient is not documented as being in remission (use F11.21 if sustained remission is documented)
• No intoxication or intoxication delirium is present at this encounter
• Documentation reflects dependence-level physiological or behavioral criteria, not abuse-level criteria

For practices managing opioid use disorder patients, compliance management tools that flag incomplete documentation before claim submission can significantly reduce F11.20-related denials.

The F11.2x Code Family: ICD 10 Code F11.20 and Related Subcategories

F11.20 belongs to the F11.2x subcategory, which covers all forms of opioid dependence with varying complications and clinical states. Understanding where ICD 10 Code F11.20 fits within the full code family prevents both under-coding and over-coding at each encounter.

Selecting the wrong F11.2x subcategory creates a mismatch between documented clinical status and the submitted code, which is a primary reason for claim denial and post-payment audit risk. Claims management software that validates code specificity before submission helps practices avoid this category of error.

F11.20 vs F11.10: Opioid Dependence vs Opioid Abuse

The most consequential coding distinction in opioid-related ICD-10-CM is between F11.10 (Opioid abuse, uncomplicated) and ICD 10 Code F11.20 (Opioid dependence, uncomplicated). These are not interchangeable. Coding one when the clinical record supports the other is a known audit trigger across both Medicare and Medicaid.

Defining the Clinical Boundary

Under ICD-10-CM classification and WHO ICD-10 definitions, opioid dependence carries a stronger physiological and behavioral reliance than opioid abuse. Dependence typically involves tolerance, withdrawal phenomena, and a compulsive pattern of use despite adverse consequences. Abuse reflects a harmful pattern of use without the full syndrome of dependence.

The ICD-10-CM coding hierarchy reinforces this: when a patient meets criteria for both abuse and dependence, the Official Guidelines instruct coders to assign only the dependence code. F11.20 takes precedence over F11.10. Documenting abuse when dependence is clinically evident is an under-coding error that may not accurately reflect patient acuity or support appropriate treatment authorization.

Side-by-Side Comparison

Psychiatry EMR platforms that embed structured substance use disorder assessments within the clinical note workflow help providers capture the documentation needed to justify F11.20 rather than defaulting to F11.10.

Documentation Requirements for ICD 10 Code F11.20

Payers, auditors, and compliance reviewers look for specific clinical language to support ICD 10 Code F11.20. Notes that simply state “opioid dependence” without supporting criteria are a common denial trigger. Strong documentation reflects the clinical complexity behind the code and reduces the risk of post-payment recoupment.

Required Documentation Elements

According to the CDC/NCHS ICD-10-CM coding tool and the ICD-10-CM Official Guidelines for Coding and Reporting (FY2026), clinical documentation supporting F11.20 should address the following elements at the point of care.

• Explicit dependence diagnosis: The provider must document “opioid dependence” by name, not merely “opioid use” or “opioid misuse.” Vague language does not meet the coding threshold.
• Substance specificity: Identify the opioid(s) involved (e.g., heroin, oxycodone, methadone as a substance of dependence, fentanyl). Specificity strengthens audit defensibility.
• Absence of current complications: Note that the encounter does not involve active withdrawal, intoxication, or other F11.2x-level complications. This explicitly justifies the “uncomplicated” descriptor.
• Treatment context: Document whether the patient is receiving MOUD (buprenorphine, methadone for OUD, naltrexone) and add Z79.891 (long-term use of opioid analgesic) as a secondary code when maintenance therapy is ongoing.
• DSM-5 criteria reference: Including documented DSM-5 criteria for moderate or severe OUD (at least 4 or 6 criteria respectively) strengthens the clinical basis for the dependence classification.

Practices using digital intake forms can pre-structure substance use history collection to capture these elements consistently, reducing the time clinicians spend retrofitting notes after the encounter.

MOUD Pairing: Z79.891 and Z51.81

When a patient with F11.20 is actively receiving medication for opioid use disorder, two additional codes are commonly submitted as secondary diagnoses. Z79.891 (Long-term use of opioid analgesic) flags maintenance therapy for payer review. Z51.81 (Encounter for therapeutic drug monitoring) applies when the visit purpose includes monitoring medication levels, such as buprenorphine or methadone serum concentration checks.

Payer policies on these pairings vary. Some Medicare Administrative Contractors have specific Local Coverage Determinations (LCDs) governing MOUD billing. Verifying payer-specific guidelines before submitting F11.20 alongside Z79.891 is standard practice for high-volume OUD treatment settings. The Echo AI documentation tool within Pabau can help clinicians generate structured notes that capture MOUD status and medication monitoring context within each encounter.

Reduce OUD Coding Errors Before Claims Leave Your Practice

Pabau's claims management software gives OUD treatment practices a structured workflow for validating ICD-10 code specificity, tracking F11.20 billing accuracy, and flagging incomplete documentation before submission.

Book a demo

DSM-5 and OUD Severity: How F11.20 Fits the Clinical Picture

A common point of confusion in OUD coding involves the relationship between ICD-10-CM codes and DSM-5 severity ratings. The DSM-5 classifies OUD on a spectrum: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). ICD-10-CM’s structure maps differently, which creates a documentation challenge for providers who rely on DSM-5 criteria in their clinical notes.

According to the American Journal of Managed Care, ICD-10-CM guidelines reserve F11.20 for moderate or severe OUD, consistent with WHO dependence criteria. The F11.10 (opioid abuse) subcategory maps more closely to mild OUD. However, the same peer-reviewed study notes documented discordance in clinical practice, where providers sometimes apply F11.20 without confirming that the documentation crosses the dependence threshold.

The practical implication: a patient documented with mild OUD under DSM-5 criteria (2-3 criteria met) should receive F11.10, not F11.20. Moderate and severe OUD (4 or more criteria) supports F11.20, provided no active complications are documented. This distinction matters for SAMHSA reporting, insurance authorization, and audit defensibility. Providers using therapy practice management systems that integrate DSM-5 screening tools can reduce this source of diagnostic-to-code mismatch.

F11.21: Remission Coding and When to Transition from F11.20

F11.21 (Opioid dependence, in remission) applies when the treating provider documents that the patient’s opioid dependence is in sustained remission. This transition requires explicit clinical language in the record. “Patient doing well on Suboxone” does not constitute a remission declaration. The provider must state “in remission” or equivalent clinical language, supported by a defined period without criteria for active dependence.

Until sustained remission is formally documented, F11.20 remains the appropriate code, even for patients who are stable on MOUD. Prematurely transitioning to F11.21 without supporting documentation is a coding error that can affect coverage for ongoing MOUD treatment.

Billing Tips and Common ICD 10 Code F11.20 Coding Errors

ICD 10 Code F11.20 carries specific billing considerations that differ from most behavioral health diagnoses. OUD treatment billing involves overlapping Medicare, Medicaid, and commercial payer rules, and the Substance Abuse and Mental Health Services Administration (SAMHSA) requirements add a regulatory layer for MOUD-prescribing practices. Practices relying on claims management software to automate code validation catch the most common F11.20 billing errors before they reach the payer.

Common ICD 10 Code F11.20 Billing Errors

• Coding F11.10 when documentation supports F11.20: The most frequent error. Providers use “abuse” language in notes but meet dependence criteria clinically. Coders must default to dependence when both are supportable.
• Using F11.20 without specifying the encounter type: F11.20 alone does not describe the purpose of the visit. Pair it with the appropriate evaluation and management code and document medical decision-making complexity.
• Omitting Z79.891 for MOUD patients: When a patient is on maintenance buprenorphine or methadone for OUD, omitting Z79.891 can result in claim denial or reduced reimbursement under some payer contracts.
• Assigning F11.20 when F11.21 is warranted: Continuing to bill F11.20 after the provider has documented remission misrepresents the patient’s clinical status and may constitute a compliance violation.
• Applying F11.20 to methadone used therapeutically: When methadone is prescribed as MOUD (not as the substance of dependence), F11.20 does not apply to the methadone itself. Use Z79.891 instead.

Telehealth visits for OUD treatment follow the same ICD-10-CM coding rules as in-person encounters. F11.20 is applicable regardless of visit modality. However, the telehealth billing context adds complexity through place-of-service codes and modifier requirements that vary by payer. Ensure your billing team applies the correct POS code alongside F11.20 for remote OUD treatment claims.

For practices seeking verified code lookup resources, the AAPC Codify ICD-10-CM lookup provides searchable access to the 2026 code set, including F11.20 inclusion terms and coding notes. Always cross-reference against the CMS official guidelines for payer-facing billing decisions.

Expert Picks

Need a structured psychiatric evaluation framework for OUD documentation? Psychiatric Evaluation Template provides a step-by-step guide for comprehensive mental health assessments that support diagnostic coding accuracy.

Working with anxiety-related ICD-10 codes alongside OUD diagnoses? Situational Anxiety ICD-10 Code covers related coding for comorbid anxiety presentations common in OUD treatment populations.

Looking for mental health EMR software built for behavioral health practices? Mental Health EMR Software outlines Pabau’s documentation and billing workflow features for mental health and substance use disorder practices.

Conclusion

Opioid dependence billing errors cost practices revenue and create audit exposure. ICD 10 Code F11.20 is technically straightforward as a billable code, but its clinical application requires precise documentation: dependence criteria met, no active complications at the encounter, and clear separation from F11.10 abuse coding. Getting that documentation right is the difference between clean claims and denial patterns.

Pabau’s claims management software gives OUD treatment practices a structured layer between clinical documentation and claim submission, helping coders validate F11.20 specificity, flag MOUD pairing requirements, and reduce post-payment audit risk. To see how Pabau supports behavioral health billing workflows, book a demo.

Frequently Asked Questions